Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)

被引:165
|
作者
Ries, SJ
Brandts, CH
Chung, AS
Biederer, CH
Hann, BC
Lipner, EM
McCormick, F
Korn, WM [1 ]
机构
[1] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA
关键词
D O I
10.1038/80466
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The adenovirus mutant dl1520 (ONYX-015) does not express the E1B-55K protein that binds and inactivates p53. This virus replicates in tumor cells with mutant p53, but not in normal cells with functional p53. Although intra-tumoral injection of dl1520 shows promising responses in patients with solid tumors, previous in vitro studies have not established a close correlation between p53 status and dl1520 replication. Here we identify loss of p14(ARF) as a mechanism that allows dl1520 replication in tumor cells retaining wild-type p53. We demonstrate that the re-introduction of p14(ARF) into tumor cells with wild-type p53 suppresses replication of dl1520 in a p53-dependent manner. Our study supports the therapeutic use of dl1520 in tumors with lesions within the p53 pathway other than mutation of p53.
引用
收藏
页码:1128 / 1133
页数:6
相关论文
共 46 条
  • [1] Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
    Stefan J. Ries
    Christian H. Brandts
    Alicia S. Chung
    Carola H. Biederer
    Byron C. Hann
    Ettie M. Lipner
    Frank McCormick
    W. Michael Korn
    [J]. Nature Medicine, 2000, 6 : 1128 - 1133
  • [2] ONYX-015 selectivity and the p14ARF pathway
    Frank McCormick
    [J]. Oncogene, 2000, 19 : 6670 - 6672
  • [3] ONYX-015 selectivity and the p14ARF pathway
    McCormick, F
    [J]. ONCOGENE, 2000, 19 (56) : 6670 - 6672
  • [4] Evidence that replication of the antitumor adenovirus ONYX-015 is not controlled by the p53 and p14ARF tumor suppressor genes
    Edwards, SJ
    Dix, BR
    Myers, CJ
    Dobson-Le, D
    Huschtscha, L
    Hibma, M
    Royds, J
    Braithwaite, AW
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (24) : 12483 - 12490
  • [5] Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?
    Dix, BR
    Edwards, SJ
    Braithwaite, AW
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (12) : 5443 - 5447
  • [6] Synergistic cytotoxicity against human tumor cell lines by oncolytic adenovirus dl1520 (ONYX-015) and melphalan
    Ferguson, Peter J.
    Sykelyk, Alexander
    Figueredo, Rene
    Koropatnick, James
    [J]. TUMORI, 2016, 102 (01) : 31 - 39
  • [7] Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells
    Jonathan Madara
    James A Krewet
    Maulik Shah
    [J]. Molecular Cancer, 4
  • [8] Heat shock protein 72 expression allows permissive replication of oncolytic adenovirus dl1520 (ONYX-015) in rat glioblastoma cells
    Madara, Jonathan
    Krewet, James A.
    Shah, Maulik
    [J]. MOLECULAR CANCER, 2005, 4 (1)
  • [9] Potentiation of radiation therapy by the oncolytic adenovirus dl1520 (ONYX-015) in human malignant glioma xenografts
    B Geoerger
    J Grill
    P Opolon
    J Morizet
    G Aubert
    Y Lecluse
    V W van Beusechem
    W R Gerritsen
    D H Kirn
    G Vassal
    [J]. British Journal of Cancer, 2003, 89 : 577 - 584
  • [10] Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015):: results of Phase I and II trials
    Kirn, D
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (03) : 525 - 538